China Shineway Pharmaceutical Group Limited Stock
Stocks
2877
KYG2110P1000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.260 HKD | +0.36% |
|
-1.90% | -3.95% |
| 05-07 | China Shineway Pharmaceutical's Turnover Slides 18% in Q1 | MT |
| 05-07 | China Shineway Pharmaceutical posts Q1 turnover of RMB624 mln | RE |
| Market Cap | 5.39B 6.24B 796M 698M 650M 598M 1.12B 76.02B 1.14B 7.71B 3.02B 37.7B 2.99B 2.92B 130B | P/E 2026 * |
5.64x | P/E 2027 * | 5.02x |
|---|---|---|---|---|---|
| Enterprise Value | 5.39B 6.24B 796M 698M 650M 598M 1.12B 76.02B 1.14B 7.71B 3.02B 37.7B 2.99B 2.92B 130B | EV / Sales 2026 * |
1.78x | EV / Sales 2027 * | 1.65x |
| Free-Float |
33.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.36% | ||
| 1 week | -1.90% | ||
| Current month | +11.92% | ||
| 1 month | +11.17% | ||
| 3 months | -14.67% | ||
| 6 months | -14.49% | ||
| Current year | -3.95% |
| 1 week | 8.12 |  | 8.46 |
| 1 month | 7.21 | | 8.5 |
| Current year | 7.21 | | 10.47 |
| 1 year | 7.21 | | 10.47 |
| 3 years | 6.55 | | 10.76 |
| 5 years | 4.63 | | 10.76 |
| 10 years | 4.6 | | 18.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
King Kuen Hung
IRC | Investor Relations Contact | 60 | - |
Baochang Liu
SAM | Sales & Marketing | 46 | 01/12/2019 |
Bun Ching Lee
AUD | Comptroller/Controller/Auditor | 53 | 01/02/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
CHM | Chairman | 70 | 14/08/2002 |
Yun Xia Xin
BRD | Director/Board Member | 62 | 14/08/2002 |
Hui Min Li
BRD | Director/Board Member | 58 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/10/22 | Other | Director | 280,000 | 0.0339% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | -1.90% | -1.67% | +1.10% | 793M | |
| +0.15% | +1.04% | +16.34% | +74.17% | 49.38B | |
| +0.53% | +3.50% | +61.24% | +112.76% | 36.35B | |
| +2.50% | +0.21% | -5.74% | +23.32% | 11.87B | |
| -0.81% | -4.33% | +12.58% | +69.24% | 11.53B | |
| +0.38% | -2.06% | +34.70% | +131.86% | 8.99B | |
| -0.92% | -0.35% | +48.24% | -9.27% | 7B | |
| -0.51% | -2.10% | +12.20% | +32.13% | 6.76B | |
| -0.52% | -2.45% | +1.83% | +165.65% | 6.46B | |
| -1.32% | -11.87% | -32.46% | -0.24% | 5.49B | |
| Average | -0.02% | -1.01% | +14.73% | +60.07% | 14.46B | |
| Weighted average by Cap. | +0.21% | +0.51% | +25.41% | +77.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.03B 3.51B 448M 393M 366M 337M 632M 42.82B 642M 4.35B 1.7B 21.24B 1.68B 1.65B 73.37B | 3.26B 3.78B 482M 423M 394M 362M 679M 46.05B 691M 4.67B 1.83B 22.84B 1.81B 1.77B 78.91B |
| Net income | 956M 1.11B 141M 124M 115M 106M 199M 13.49B 202M 1.37B 536M 6.69B 530M 519M 23.12B | 1.07B 1.24B 158M 139M 129M 119M 223M 15.13B 227M 1.54B 601M 7.5B 595M 582M 25.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | HK$8.260 | +0.36% | 355,600 |
| 27/07/26 | HK$8.230 | -0.12% | 292,845 |
| 24/07/26 | HK$8.240 | +0.12% | 410,000 |
| 23/07/26 | HK$8.230 | -0.12% | 633,000 |
| 22/07/26 | HK$8.240 | -1.20% | 341,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2877 Stock
Select your edition
All financial news and data tailored to specific country editions
